Suppr超能文献

药物性高钾血症:老问题与新诱因

Drug-induced hyperkalemia: old culprits and new offenders.

作者信息

Perazella M A

机构信息

Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

Am J Med. 2000 Sep;109(4):307-14. doi: 10.1016/s0002-9343(00)00496-4.

Abstract

Prescribed medications, over-the-counter drugs, and nutritional supplements are used by many patients. Although most of these products are well tolerated, drug-induced hyperkalemia may develop in patients with underlying renal impairment or other abnormalities in potassium handling. Drug-induced hyperkalemia most often occurs from impaired renal potassium excretion. However, disturbed cellular uptake of a potassium load as well as excessive ingestion or infusion of potassium-containing substances may also occur. Physicians must be aware of medications that can precipitate hyperkalemia, how these drugs induce alterations in potassium homeostasis, and the patient characteristics that increase the risk of hyperkalemia.

摘要

许多患者会使用处方药、非处方药和营养补充剂。虽然这些产品大多耐受性良好,但在有潜在肾功能损害或钾代谢其他异常的患者中,可能会发生药物性高钾血症。药物性高钾血症最常见于肾钾排泄受损。然而,钾负荷的细胞摄取紊乱以及含钾物质的过量摄入或输注也可能发生。医生必须了解可引发高钾血症的药物、这些药物如何引起钾稳态改变以及增加高钾血症风险的患者特征。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验